Isoray Announces Transformational Merger and Fourth Quarter and Full-Year Fiscal Year End 2022 Financial Results

IEDA Board approves assistance for two Corridor startups

The USPTO Issues a Patent to Cellular Engineering Technologies For Producing Safer Induced Pluripotent Stem Cells

VIDA streamlines respiratory clinical trials with artificial intelligence

VIDA Streamlines Respiratory Clinical Trials with Artificial Intelligence (AI)

Viewpoint Molecular Targeting™ Receives FDA Clearance of Investigational New Drug Application for Phase 1 Imaging Study for VMT-a-NET for Neuroendocrine Tumors

NIH innovation grants propelling Viewpoint Molecular forward

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

Viewpoint Molecular Targeting® Partners with Industry Leader Pepscan to Accelerate Peptide Discovery Program